a continuity of drug development for diseases across the lifespan
Published 7 months ago • 25 plays • Length 53:31Download video MP4
Download video MP3
Similar videos
-
17:31
sbs day 2 - inc current perspective: conducting gene therapy clinical trials
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
11:08
rare disease endpoint advancement rdea pilot program
-
30:31
drug development and regulation in the age of precision medicine
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
1:00:27
central blood pressure: the future of bp management? with dr remi goupil
-
48:44
drug transport across the blood brain barrier with dr. sadhana jackson
-
4:33
drug discovery and development | basic science series
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
26:24
critical path institute: 15 years of impact
-
3:48
how has the presence or lack of data changed drug development for platelet disorders?
-
57:41
global perspectives of pediatric drug development
-
4:33
the drug development process
-
4:12
why are high-quality standardized databases so critical for drug development?
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
2:27
jane larkindale - why are c-path drug development tools important in rare disease drug development?
-
46:37
clinical trial simulation tools advancing treatments in rare disease
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
57:08
industry perspective on drug development in rare diseases
-
17:31
an overview of the drug development process
-
3:44
rare disease challenges in each step of the drug development process